New York State Academy of Dentistry

19-02 Whitestone Expressway, Suite 204
Whitestone, NY 11357
Phone: (718) 747-3353
Fax: (718) 747-3355

Continuing Education

October 14, 2016 at 8:30 AM to 4:00 PM

Pricing

Member $75.00
Non-Member $100.00
Staff/Auxiliary $75.00
Resident/New Dentist $50.00

General Information

Course Number 0030
Provider New York State Learning Center
Speaker Dr. Mana Saraghi
Type/Category Lecture
Credits 7 MCE

Lecture Topics: Local Anesthetic Primer Post-op Analgesia and Pain Control Nitrous Oxide Review An Introduction to Dental Sedation Sedation Complications and Emergencies: A Must for the Oral and IV Sedation Provider

The New York AGD Presents

"Local Anesthetic Review, Advances in Local Anesthesia, Novel Delivery Systems "

Date: Friday, October 14, 2016

Location: 1902 Whitestone Expressway, Suite 204, Whitestone, NY 11357

Registration: 8:00am  Lecture 8:30am to 4:00pm

Course Code 132

   7 MCE Credit Hours

About the Speaker: Dr. Mana Saraghi

Dr Saraghi is a board certified dentist anesthesiologist.  Her anesthesia practice focuses on providing pain and anxiety control for dental patients, including pediatric, adult, geriatric, and special needs patients. She provides thorough, customized anesthesia to best accommodate the combined demands of the patient, the procedure, and the operating dentist.  Dr Saraghi is also an Attending Dentist Anesthesiologist at St Barnabas hospital in the Bronx, NY and a Clinical Assistant Professor at the Herman Ostrow School of Dentistry of the University of Southern California in Los Angeles, CA.  She has also served as a scientific advisor to several pharmaceutical companies.  Dr Saraghi has authored numerous peer-reviewed articles on several subjects including: medical emergencies, multimodal analgesia, and the pharmacology of local anesthetics, sedatives, and nitrous oxide.

Course Description:

Local anesthetics are the most commonly administered medications in dentistry. It is imperative for every dentist to be proficient in their knowledge of local anesthesia pharmacology as well as in new local anesthetics and delivery systems. A newly approved local anesthetic, Kovanaze, is administered as an intranasal spray; such "needle-free" anesthetics will be very alluring to patients as the perceived pain is a considerable source of anxiety for many dental patients. Commercially available buffering systems have also entered the market, offering clinicians the ability to reduce the discomfort with and increase the onset of action for injected local anesthetics. The Wand(TM), is another commercially available device that offers reduced pain, anxiety, and discomfort as compared to the traditional dental local anesthetic syringe.

Profound post operative local anesthesia can reduce patient discomfort and reduce the amount of analgesics consumed, and thereby reduce the side effect profile of those medications. In light of the national opioid epidemic and increased regulations involving the prescription of controlled substances, a novel ultralong acting local anesthetic formulation may dramatically reduce the amount of opioids consumed as well as reduce the administrative burden on the dental practitioner in prescribing such medications in compliance with new regulations. 

The goals of this lecture are to review the following:

-Pharmacology of local anesthetics and vasoconstrictors, including mechanism of action, indications, contraindications, and drug interactions

-How to prevent an overdose: local anesthetic and vasoconstrictor dosing using quick, easy, and reliable methods for chairside calculation of maximum recommended doses 

-Local anesthetic systemic toxicity, prevention, recognition, and management.

-New local anesthetics and local anesthetic delivery systems: a practical guide for the practitioner to integrate the latest new local anesthetics and delivery systems to give pain-free injections 

-Exparel - a liposomal bupivacaine formulation that delivers prolonged anesthesia at the site of infiltration to reduce the need for post operative analgesics

-Kovanaze - an intranasal tetracaine formulation that involves no needles and provides adequate anesthesia for dental procedures 

-Oraverse - a local anesthetic reversal agent to reduce the duration of post operative soft tissue anesthesia 

-Buffering systems - to reduce the onset and discomfort associated with local anesthetic adminstration

-The wand - a novel delivery system to reduce the pain, discomfort, and anxiety associated with conventional dental local anesthetic syringes

Course includes continential breakfast and lunch

The New York State constituent of the Academy of General Dentistry is an approved program provider.  The sponsor’s formal CDE programs are acceptable by the AGD for Fellowship and Mastership and membership maintenance credit.  This course is also acceptable for MCE Licensing Maintenance.  The current term of approval extends from 01/01/15 to 12/31/18.  AGD Code #219318.